Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhang Limeng
Clinical Significance of miRNA - 106a in Non-Small Cell Lung Cancer Patients Who Received Cisplatin Combined With Gemcitabine Chemotherapy
Cancer Biology and Medicine
Cancer Research
Oncology
Related publications
Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Refractory Non-Small-Cell Lung Cancer Responding to Combination Chemotherapy With Gemcitabine and Cisplatin
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Clinical Observation of Docetaxel or Gemcitabine Combined With Cisplatin in the Chemotherapy After Surgery for Stage II-III Non-Small Cell Lung Cancer
West Indian Medical Journal
Medicine
162P: Molecular Markers in Advanced Non Small Cell Lung Cancer Patients Receiving Gemcitabine & Cisplatin
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Phase II Study of Docetaxel Alternating With Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
155P: PD-L1 Polymorphism Can Predict Clinical Outcomes of Non-Small Cell Lung Cancer Patients Treated With First-Line Paclitaxel–cisplatin Chemotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Gemcitabine Plus Vinorelbine in Elderly or Unfit Patients With Non-Small Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Chemotherapy for Non-Small Cell Lung Cancer in Elderly Patients
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Prognostic Significance of CD31 Expression in Patients With Non-Small-Cell-Lung Cancer
Advances in Lung Cancer
